4//SEC Filing
Tesi Raymond Joseph 4
Accession 0001213900-24-052113
CIK 0001711754other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:30 PM ET
Size
5.4 KB
Accession
0001213900-24-052113
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Tesi Raymond Joseph
DirectorPresident & CEO10% Owner
Transactions
- Award
Option (right to buy)
2024-06-10+37,882→ 37,882 totalExercise: $8.72Exp: 2034-06-09→ Common Stock (37,882 underlying)
Footnotes (1)
- [F1]The option was granted pursuant to the INmune Bio Inc. 2021 Stock Incentive Plan. The option is 100% vested and exercisable as of the grant date.
Documents
Issuer
Inmune Bio, Inc.
CIK 0001711754
Entity typeother
Related Parties
1- filerCIK 0001767280
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:30 PM ET
- Size
- 5.4 KB